Posted in | News | Gold | Iron Ore | Discoveries

Riverside Resources, Choice Gold Announce Discovery of Oxide Zone at Sugarloaf Peak

Riverside Resources and Choice Gold have announced a new oxide gold zone discovery at the Sugarloaf Peak project in Arizona.

Recent and historical drill hole locations at Sugarloaf Peak Gold Project

The company has intersected 1.76 g/t gold over 9.91 m in the drill hole SLG-11-04. The location of the discovery hole is around 1 km to the northeast part from the previous prominent mineralized zone’s core structure.

The CEO and President of Riverside, has commented that the project’s near surface oxide section has discovered positive shallow mineralization and has extended the project’s prospective towards progress and also added that these Sugarloaf project results are primarily reported from the summer drilling campaigns, which is financially supported by four partners, and currently, shareholders can anticipate stable drill results all through the fall.

The company has Choice Gold’s 8.6 M shares, and will get further 5 M shares during the period of the option contract consequent to the deal conditions.

Gold exists in the tectonic and faulting brecciation, which has strongly oxidized interval, in the hole SGL-11-04. Jarosite and hematite are present more than iron oxides and sulphides were not found. The company has identified several quartz crystals dispersed along the intervals, signifying that the host rock may possibly be a strongly changed felsic volcanic rock. It has encountered values of anomalous gold in the first 200 m in the hole SGL-11-01 and SGL-11-02, with grades of 125 ppb gold present in the sericitized felsic volcanic units, and also intersected 0.78 g/t gold in hole SGL-11-01 and 0.53 g/t gold in hole SGL-11-02 as irregular values. Gold finding along with the hematite variation has formed a fresh exploration target type and will manipulate the subsequent planned drill phase.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 18). Riverside Resources, Choice Gold Announce Discovery of Oxide Zone at Sugarloaf Peak. AZoMining. Retrieved on October 04, 2024 from https://www.azomining.com/News.aspx?newsID=5100.

  • MLA

    Scanlon, Joel. "Riverside Resources, Choice Gold Announce Discovery of Oxide Zone at Sugarloaf Peak". AZoMining. 04 October 2024. <https://www.azomining.com/News.aspx?newsID=5100>.

  • Chicago

    Scanlon, Joel. "Riverside Resources, Choice Gold Announce Discovery of Oxide Zone at Sugarloaf Peak". AZoMining. https://www.azomining.com/News.aspx?newsID=5100. (accessed October 04, 2024).

  • Harvard

    Scanlon, Joel. 2019. Riverside Resources, Choice Gold Announce Discovery of Oxide Zone at Sugarloaf Peak. AZoMining, viewed 04 October 2024, https://www.azomining.com/News.aspx?newsID=5100.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.